Skip to content

The effect adding probiotic administration on conventional treatment in clinical findings on patients with allergic airway disease (allergic rhinitis and asthma) 2014

Evaluation of the effect adding probiotic administration on conventional treatment in clinical findings on patients with allergic airway disease (allergic rhinitis and asthma) reffered to amiralmomenin and razi hospital,rasht- 2014

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201501251138N13
Enrollment
172
Registered
2015-03-26
Start date
2015-03-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Asthma. Condition 2: allergic rhinitis. Asthma Vasomotor and allergic rhinitis

Interventions

Intervention 1: Group A Has give Routin drugs(Antihistamines,Corticosteroid) and Probiotic in Time Period 1 and Routin drugs ,Placebo in Time Time Period 2.Dosage is one capsule daily. Each Time P
Treatment - Drugs
Group A Has give Routin drugs(Antihistamines,Corticosteroid) and Probiotic in Time Period 1 and Routin drugs ,Placebo in Time Time Period 2.Dosage is one capsule daily. Each Time Period is Two Mon
Group B Has give Routin drugs(Antihistamines,Corticosteroid) and Probiotic in Time Period 1 and Routin drugs ,Placebo in Time Time Period 2.Dosage is one capsule daily.Each Time Period is Two Month ,

Sponsors

Guilan University of Medical Science, Vice Chancellor for Resarch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients 18-45 years? allergic rhinitis and asthma Exclusion criteria: Insufficient follow up; irregular drug usage; infectious diseaseduring study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: SF36 Questionnaire.

Secondary

MeasureTime frame
Asthma Symptom. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: GINA Questionnaire.;Asthma Severing. Timepoint: Starting Time( Time0) ,End of First Month,End of second Month,Beginning of fourth MonthEnd of Fifth Month and End of Sixth Month. Method of measurement: GINA.;Score of FEV1. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: Spirometry.;Alergic Rhinitis Symptom. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: SNOT 22 Questionnaire.;Score of Alergic Rhinitis Symptom Control. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: CARAT Questionnaire.;Score of Daily Treatment. Timepoint: Starting Time(time0),End of First Month,End of Second Month,Begining of Fourth Month,End of Fifth Month and End of sixth Month. Method of measurement: SMS Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mirmohammad Jalali

Guilan University of Medical Sciences

mmjalali@gmail.com+98 13 3322 5242

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026